1. Home
  2. LCID vs AMRX Comparison

LCID vs AMRX Comparison

Compare LCID & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$6.23

Market Cap

3.7B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.55

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
AMRX
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
LCID
AMRX
Price
$6.23
$12.55
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$15.71
$15.60
AVG Volume (30 Days)
15.4M
1.3M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.22
Revenue
$595,271,000.00
N/A
Revenue This Year
$71.67
$4.48
Revenue Next Year
$89.72
$7.13
P/E Ratio
N/A
$57.32
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$7.02
52 Week High
$25.22
$15.42

Technical Indicators

Market Signals
Indicator
LCID
AMRX
Relative Strength Index (RSI) 25.64 45.67
Support Level $2.11 $12.50
Resistance Level $10.64 $12.85
Average True Range (ATR) 0.65 0.49
MACD -0.23 0.01
Stochastic Oscillator 1.40 28.01

Price Performance

Historical Comparison
LCID
AMRX

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: